Li-rong Zhu
Zhenjiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Journal: Cancer biomarkers : section A of Disease markers
Published: August 09, 2021
Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis.
Journal: Journal of cellular physiology
Published: June 13, 2020
Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Journal: Japanese journal of clinical oncology
Published: November 27, 2014
Survivin mRNA expression in blood as a predictor of the response to EGFR-tyrosine kinase inhibitors and prognosis in patients with non-small cell lung cancer.
Journal: Medical oncology (Northwood, London, England)
Published: December 22, 2013
Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer.
Journal: BMC cancer
Published: October 31, 2013
LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: July 16, 2013
Detection of FHIT and p16 mRNA deletion in biopsy specimens obtained by bronchoscopy for the diagnosis of lung cancer.
Journal: The International journal of biological markers
Published: March 25, 2013
Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
Journal: Asia-Pacific journal of clinical oncology
Published: January 24, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026